202 related articles for article (PubMed ID: 9466172)
41. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
Goldberg RJ
Drugs Aging; 1997 Aug; 11(2):119-31. PubMed ID: 9259175
[TBL] [Abstract][Full Text] [Related]
42. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
Norman TR; Burrows GD
Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
[TBL] [Abstract][Full Text] [Related]
43. Moclobemide versus fluoxetine for a major depressive episode.
Reynaert C; Parent M; Mirel J; Janne P; Haazen L
Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
[TBL] [Abstract][Full Text] [Related]
44. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
45. A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Papakostas GI; Fava M
Can J Psychiatry; 2006 Oct; 51(12):783-90. PubMed ID: 17168253
[TBL] [Abstract][Full Text] [Related]
46. Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression.
Gabelic I; Kuhn B
Acta Psychiatr Scand Suppl; 1990; 360():63. PubMed ID: 2248076
[TBL] [Abstract][Full Text] [Related]
47. Clinical overview on moclobemide.
Tiller JW
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):703-12. PubMed ID: 8255982
[TBL] [Abstract][Full Text] [Related]
48. [Neurobiology and pharmacotherapy of social phobia].
Aouizerate B; Martin-Guehl C; Tignol J
Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
[TBL] [Abstract][Full Text] [Related]
49. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
Tiller JW; Maguire KP; Davies BM
Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
[TBL] [Abstract][Full Text] [Related]
50. Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study.
Lott M; Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Katz RJ; Schaettle SC
J Clin Psychopharmacol; 1997 Aug; 17(4):255-60. PubMed ID: 9241003
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
Hebenstreit GF; Loidl M; Baumhackl U; Gallhofer B; Geretsegger C; Radmayr E; Saletu M; Schöny W; Stabl M
J Neural Transm Suppl; 1990; 32():177-84. PubMed ID: 2089087
[TBL] [Abstract][Full Text] [Related]
52. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
Newburn GM; Fraser AR; Menkes DB; Mullen PE
Aust N Z J Psychiatry; 1990 Dec; 24(4):475-9. PubMed ID: 2073222
[TBL] [Abstract][Full Text] [Related]
53. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
[TBL] [Abstract][Full Text] [Related]
54. Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia.
Pétursson H
Acta Psychiatr Scand Suppl; 1995; 386():36-9. PubMed ID: 7717093
[TBL] [Abstract][Full Text] [Related]
55. The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study.
Eur Arch Psychiatry Clin Neurosci; 1997; 247(2):71-80. PubMed ID: 9177952
[TBL] [Abstract][Full Text] [Related]
56. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
Evans L; George T; O'Sullivan B; Mitchell P; Johnson G; Adena M
Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
[TBL] [Abstract][Full Text] [Related]
57. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
58. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
Versiani M; Nardi AE; Mundim FD; Alves AB
J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
[TBL] [Abstract][Full Text] [Related]
59. Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.
Griebel G; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1997 May; 131(2):180-6. PubMed ID: 9201807
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.
Atmaca M; Kuloglu M; Tezcan E; Unal A
Hum Psychopharmacol; 2002 Dec; 17(8):401-5. PubMed ID: 12457375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
